KemPharm, Inc.
(NASDAQ : KMPH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-2.67%19.132.0%$600.14m
SHPGShire PLC Sponsored ADR
1.14%172.350.4%$144.17m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.29%143.746.8%$132.19m
PRGOPerrigo Co. Plc
2.49%71.916.8%$93.03m
JAZZJazz Pharmaceuticals Plc
-1.25%156.842.2%$64.30m
ENDPEndo International Plc
1.11%17.718.9%$59.67m
MNKMallinckrodt Plc
1.14%27.4721.1%$58.46m
SAGESAGE Therapeutics, Inc.
-1.98%122.359.6%$47.04m
ICPTIntercept Pharmaceuticals, Inc.
-1.56%102.1118.7%$46.89m
UTHRUnited Therapeutics Corporation
1.02%124.3714.4%$35.26m
CTLTCatalent Inc
1.06%41.912.4%$32.72m
ICLRICON Plc
0.03%144.964.1%$31.81m
PCRXPacira Pharmaceuticals, Inc.
3.01%45.4710.6%$25.83m
AERIAerie Pharmaceuticals, Inc.
1.86%56.406.9%$25.69m
MDCOMedicines Company
2.50%26.8921.8%$25.44m

Company Profile

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Coralville, IA.